-
1
المؤلفون: Valérie Vilgrain, Helena Pereira, Eric Assenat, Boris Guiu, Alina Diana Ilonca, Georges-Philippe Pageaux, Annie Sibert, Mohamed Bouattour, Rachida Lebtahi, Wassim Allaham, Hélène Barraud, Valérie Laurent, Elodie Mathias, Jean-Pierre Bronowicki, Jean-Pierre Tasu, Rémy Perdrisot, Christine Silvain, René Gerolami, Olivier Mundler, Jean-Francois Seitz, Vincent Vidal, Christophe Aubé, Frédéric Oberti, Olivier Couturier, Isabelle Brenot-Rossi, Jean-Luc Raoul, Anthony Sarran, Charlotte Costentin, Emmanuel Itti, Alain Luciani, René Adam, Maïté Lewin, Didier Samuel, Maxime Ronot, Aurelia Dinut, Laurent Castera, Gilles Chatellier, Elisabeth Delhom - Christol, Alina D Ilonca, Julie Lonjon, Mohamed Abdel-Rehim, Arnaud Dieudonné, Christophe Bazin, Carine Chagneau-Derrode, Patrick Borentain, Antoine Bouvier, Laurent Vervueren, Julia Chalaye, Hicham Kobeiter, Julien Edeline, Etienne Garin, Yan Rolland, Isabelle Archambeaud, Thomas Eugene, Eric Frampas, Christophe Cassinotto, Martine Guyot, Jean-Baptiste Hiriart, Bruno Lapuyade, Julien Vergniol, Philippe Bachellier, Julien Detour, Bernard Duclos, Michel Greget, Francois Habersetzer, Alessio Imperiale, Philippe Merle, Agnès Rode, Julie Morvan, Eric Nguyen-Khac, Thierry Yzet, Guillaume Baudin, Patrick Chevallier, Abakar Mahamat, Thierry Piche, Micheline Razzouk, Patrick Hillon, Romaric Loffroy, Michel Toubeau, Julie Vincent, Gabriele Barabino, Nadia Bouarioua, Muriel Cuilleron, Marie Ecochard, Nathalie Prevot-Bitot, Vincent Leroy, Julie Roux, Christian Sengel, Valérie Bourcier, Nathalie Ganne-Carrie, Olivier Seror, Sylvie Costo, Thông Dao, Jean-Pierre Pelage, Jérôme Dumortier, Francesco Giammarile, Pierre-Jean Valette, Nadia Ghazzar, Olivier Pellerin, Julien Taieb, Pierre Weinmann, Alexandra Heurgue-Berlot, Claude Marcus, Daniele Sommacale, Maria-Angéla Castilla-Lièvre, Sophie Maitre, Lysiane Marthey
المساهمون: Hôpital Beaujon, Hôpital Beaujon-Université Paris Diderot - Paris 7 (UPD7)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Centre de recherche sur l'Inflammation (CRI (UMR_S_1149 / ERL_8252 / U1149)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CIC - HEGP (CIC 1418), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Saint-Eloi, Hôpital Gui de Chauliac, Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Centre hospitalier universitaire de Poitiers (CHU Poitiers), Hôpital de la Timone [CHU - APHM] (TIMONE), Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Diderot - Paris 7 (UPD7), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)
المصدر: Lancet Oncology
Lancet Oncology, Elsevier, 2017, 18 (12), pp.1624-1636. ⟨10.1016/S1470-2045(17)30683-6⟩مصطلحات موضوعية: Male, medicine.medical_treatment, Brachytherapy, Administration, Oral, Kaplan-Meier Estimate, Liver transplantation, Gastroenterology, 0302 clinical medicine, Yttrium Radioisotopes, MESH: Carcinoma, Hepatocellular/drug therapy, education.field_of_study, Liver Neoplasms, Radiotherapy Dosage, MESH: Carcinoma, Hepatocellular/radiotherapy, Middle Aged, Sorafenib, Microspheres, MESH: Niacinamide/analogs & derivatives, 3. Good health, MESH: Liver Neoplasms/drug therapy, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Female, 030211 gastroenterology & hepatology, MESH: Phenylurea Compounds/administration & dosage, Liver cancer, medicine.drug, Adult, Niacinamide, medicine.medical_specialty, Carcinoma, Hepatocellular, Population, Antineoplastic Agents, [SDV.CAN]Life Sciences [q-bio]/Cancer, Disease-Free Survival, Drug Administration Schedule, 03 medical and health sciences, Internal medicine, medicine, Carcinoma, Humans, Neoplasm Invasiveness, education, Aged, Neoplasm Staging, Dose-Response Relationship, Drug, Performance status, business.industry, Phenylurea Compounds, medicine.disease, Survival Analysis, Surgery, MESH: Yttrium Radioisotopes/therapeutic use, Liver function, business, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37960b5209b2b33f51aee9e80e06e797Test
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01727346Test -
2
المؤلفون: Antoine Hollebecque, Sonia Extremera, Gilles Salles, Vicente Alfaro, Sandrine Aspeslagh, Mark N. Stein, Emmanuel Gyan, Salvador Fudio, Rastilav Bahleda, Arturo Soto-Matos, Jean-Charles Soria
المساهمون: Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Medical Oncology
المصدر: Anti-Cancer Drugs
Anti-Cancer Drugs, Lippincott, Williams & Wilkins, 2016, ⟨10.1097/CAD.0000000000000457⟩مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Lymphoma, Administration, Oral, Deoxycytidine, Gastroenterology, Depsipeptides/administration & dosage, 0302 clinical medicine, Depsipeptides, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Medicine, Pharmacology (medical), Prospective Studies, Fatigue, Nausea, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, 3. Good health, 030220 oncology & carcinogenesis, Toxicity, Vomiting, young adult, Female, France, medicine.symptom, medicine.drug, Niacinamide, Sorafenib, Adult, medicine.medical_specialty, Patients, [SDV.CAN]Life Sciences [q-bio]/Cancer, Peptides, Cyclic, 03 medical and health sciences, Niacinamide/administration & dosage, Refractory, Internal medicine, Humans, Adverse effect, Deoxycytidine/administration & dosage, Aged, Lymphoma/drug therapy, Pharmacology, therapy, Dose-Response Relationship, Drug, business.industry, Phenylurea Compounds, toxicity, medicine.disease, Gemcitabine, Thrombocytopenia, Neoplasms/drug therapy, SORAFENIB, 030104 developmental biology, Phenylurea Compounds/administration & dosage, Erythema, business, aged, 80 and over
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a23b85d24896c8e6b050b4cfb9ec050cTest
https://hal.archives-ouvertes.fr/hal-01791282Test -
3
المؤلفون: Lieveke Ameye, Raphaël Maréchal, Amélie Deleporte, Irina Vierasu, Erwin Woff, Thomas Guiot, Camilo Garcia, Alain Hendlisz, Thierry Delaunoit, Gauthier Demolin, Namur Gauthier, Renaud Lhommel, Patrick Flamen, Marc Van den Eynde, Stéphane Holbrechts
المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service de médecine nucléaire, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Centre du cancer
المصدر: European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43, p. 1792-1801 (2016)
European journal of nuclear medicine and molecular imaging, 43 (10مصطلحات موضوعية: Oncology, Male, Colorectal cancer, medicine.medical_treatment, Phenylurea Compounds -- administration & dosage, 030218 nuclear medicine & medical imaging, Targeted therapy, Tumoral heterogeneity, 0302 clinical medicine, Positron Emission Tomography Computed Tomography, Antineoplastic Combined Chemotherapy Protocols, Radiopharmaceuticals -- pharmacokinetics, Molecular Targeted Therapy, Fluorodeoxyglucose F18 -- pharmacokinetics, Imagerie médicale, radiologie, tomographie, Metastatic colorectal cancer, Colorectal Neoplasms -- diagnostic imaging -- drug therapy -- secondary, General Medicine, Middle Aged, Sorafenib, Treatment Outcome, Drug Monitoring -- methods, Radiology Nuclear Medicine and imaging, 030220 oncology & carcinogenesis, Fdg pet ct, Female, Original Article, Niacinamide -- administration & dosage -- analogs & derivatives, medicine.symptom, Drug Monitoring, Colorectal Neoplasms, medicine.drug, Adult, Niacinamide, medicine.medical_specialty, Sensitivity and Specificity, Capecitabine, Lesion, FDG PET-CT, 03 medical and health sciences, Fluorodeoxyglucose F18, Internal medicine, medicine, Volume reduction, Humans, Molecular Targeted Therapy -- methods, Radiology, Nuclear Medicine and imaging, Aged, business.industry, Phenylurea Compounds, Reproducibility of Results, Positron Emission Tomography Computed Tomography -- methods, medicine.disease, Capecitabine -- administration & dosage, Discontinuation, Antineoplastic Combined Chemotherapy Protocols -- administration & dosage, Radiopharmaceuticals, business, Early metabolic response assessment
وصف الملف: 1 full-text file(s): application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e0aa1f3a5363635b991f75146123099Test
https://pubmed.ncbi.nlm.nih.gov/27072811Test -
4
المؤلفون: Céline Gongora
المساهمون: Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Institut de recherche en cancérologie de Montpellier (IRCM - U896 Inserm - UM1), Université Montpellier 1 (UM1)-CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
المصدر: Molecular Cancer Therapeutics
Molecular Cancer Therapeutics, American Association for Cancer Research, 2014, 13, pp.764. ⟨10.1158/1535-7163.MCT-13-1026⟩مصطلحات موضوعية: Sorafenib, Cancer Research, Abcg2, [SDV.CAN]Life Sciences [q-bio]/Cancer, Pharmacology, urologic and male genital diseases, 03 medical and health sciences, 0302 clinical medicine, Colorectal Neoplasms/*drug therapy, medicine, Distribution (pharmacology), Animals, Humans, heterocyclic compounds, Neoplasm Proteins/*genetics, neoplasms, ComputingMilieux_MISCELLANEOUS, 030304 developmental biology, 0303 health sciences, biology, Chemistry, Resistance response, ATP-Binding Cassette Transporters/*genetics, Camptothecin/*analogs & derivatives, Phenylurea Compounds/*administration & dosage, Blood proteins, female genital diseases and pregnancy complications, digestive system diseases, 3. Good health, Irinotecan, Niacinamide/*analogs & derivatives, Oncology, 030220 oncology & carcinogenesis, biology.protein, Steady state (chemistry), medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5f54a702471cb25ea39806909e64549Test
https://hal.umontpellier.fr/hal-02168059Test